AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Preisler, HD Venugopal, P Gregory, SA Adler, S Gezer, S Hsu, WT Manson, S Larson, A Jajeh, A Slvinick, D Galvez, A
Citation: Hd. Preisler et al., High remission rate in acute myeloblastic leukemia with only two days of chemotherapy, LEUK LYMPH, 41(3-4), 2001, pp. 333-336

Authors: Gregory, SA Vose, J Modiano, M Kraemer, K Rifkin, R Rubin, A Menduni, T Ghalie, R
Citation: Sa. Gregory et al., Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicin- or mitoxantrone-containing regimen, LEUK LYMPH, 40(3-4), 2001, pp. 315-324

Authors: Enschede, SH Shahidi, H Venugopal, P Riley, MB Huang, RW Jajeh, A Preisler, HD Gregory, SA
Citation: Sh. Enschede et al., Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma, LEUK LYMPH, 40(3-4), 2001, pp. 325-334

Authors: Sivaraman, S Venugopal, P Ranganathan, R Deshpande, CG Huang, X Jajeh, A Gregory, SA O'Brien, T Preisler, HD
Citation: S. Sivaraman et al., Effect of interferon-alpha on CD20 antigen expression of B-cell chronic lymphocytic leukemia, CYTOK CELL, 6(2), 2000, pp. 81-87

Authors: Preisler, HD Li, B Yang, J Huang, RW Devemy, E Venugopal, P Tao, M Chopra, H Gregory, SA Adler, S Sivaraman, S Toofanfard, P Jajeh, A Galvez, A Robin, E
Citation: Hd. Preisler et al., Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4, CLIN CANC R, 6(3), 2000, pp. 807-812

Authors: Sivaraman, S Deshpande, CG Ranganathan, R Huang, X Jajeh, A O'Brien, T Huang, RW Gregory, SA Venugopal, P Preisler, HD
Citation: S. Sivaraman et al., Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: A new role for TNF alpha?, MICROSC RES, 50(3), 2000, pp. 251-257

Authors: Preisler, HD Venugopal, P Gregory, SA Hsu, WT Loew, J Adler, S Gezer, S Creech, S Galvez, A Slivnick, D Andric, T Larson, RA Jajeh, A
Citation: Hd. Preisler et al., Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine), LEUK RES, 24(8), 2000, pp. 671-680

Authors: Venugopal, P Sivaraman, S Huang, XK Nayini, J Gregory, SA Preisler, HD
Citation: P. Venugopal et al., Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia, LEUK RES, 24(5), 2000, pp. 411-415

Authors: Mundle, SD Mativi, BY Cartlidge, JD Dangerfield, B Broady-Robinson, L Li, BR Shetty, V Venugopal, P Gregory, SA Preisler, HD Raza, A
Citation: Sd. Mundle et al., Signal antonymy unique to myelodysplastic marrows correlates with altered expression of E2F1, BR J HAEM, 109(2), 2000, pp. 376-381

Authors: Lamy, T Bauer, FA Liu, JH Li, YX Pillemer, E Shahidi, H Gregory, SA Zambello, R Marcolongo, R Semenzato, G Loughran, TP
Citation: T. Lamy et al., Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice, BR J HAEM, 108(4), 2000, pp. 717-723

Authors: Gregory, SA Tifft, WG Moody, JW Newberry, MV Hall, SM
Citation: Sa. Gregory et al., The Arizona-New Mexico spectroscopic survey of galaxies. I. Data for the western end of the Perseus supercluster, ASTRONOM J, 119(2), 2000, pp. 545-566

Authors: Gregory, SA Tifft, WG Moody, JW Newberry, MV Hall, SM
Citation: Sa. Gregory et al., The Arizona-New Mexico spectroscopic survey of galaxies. II. Structures inthe Perseus supercluster, ASTRONOM J, 119(2), 2000, pp. 567-572

Authors: Gregory, SA Tifft, WG Moody, JW Newberry, MV Hall, SM
Citation: Sa. Gregory et al., The Arizona-New Mexico spectroscopic survey of galaxies. III. On galaxy populations, ASTRONOM J, 119(2), 2000, pp. 573-579

Authors: Mundle, SD Mativi, BY Bagai, K Feldman, G Cheema, P Gautam, U Reza, S Cartlidge, JD Venugopal, P Shetty, V Gregory, SA Robin, E Rifkin, S Shah, R Raza, A
Citation: Sd. Mundle et al., Spontaneous down-regulation of Fas-associated phosphatase-1 may contributeto excessive apoptosis in myelodysplastic marrows, INT J HEMAT, 70(2), 1999, pp. 83-90

Authors: Mundle, S Venugopal, P Shetty, V Ali, A Chopra, H Handa, H Rose, S Mativi, BY Gregory, SA Preisler, HD Raza, A
Citation: S. Mundle et al., The relative extent and propensity of CD34(+) vs. CD34(-) cells to undergoapoptosis in myelodysplastic marrows, INT J HEMAT, 69(3), 1999, pp. 152-159

Authors: Venugopal, P Leslie, WT O'Brien, T Gregory, SA
Citation: P. Venugopal et al., CD20-negative relapse after I-131-anti-CD20 therapy, J CL ONCOL, 17(11), 1999, pp. 3692-3693

Authors: Mundle, SD Ali, A Cartlidge, JD Reza, S Alvi, S Showel, MM Mativi, BY Shetty, VT Venugopal, P Gregory, SA Raza, A
Citation: Sd. Mundle et al., Evidence for involvement of tumor necrosis factor-alpha in apoptotic deathof bone marrow cells in myelodysplastic syndromes, AM J HEMAT, 60(1), 1999, pp. 36-47

Authors: Mundle, SD Reza, S Ali, A Mativi, BY Shetty, V Venugopal, P Gregory, SA Raza, A
Citation: Sd. Mundle et al., Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes, CANCER LETT, 140(1-2), 1999, pp. 201-207

Authors: Shahidi, H Vottero, A Stratakis, CA Taymans, SE Karl, M Longui, CA Chrousos, GP Daughaday, WH Gregory, SA Plate, JMD
Citation: H. Shahidi et al., Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia, BIOC BIOP R, 254(3), 1999, pp. 559-565
Risultati: 1-19 |